Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06127797 · ClinicalTrials.gov registry record

Surveillance MRI Registry for Patients Who Had Breast Cancer With Dense Breast Tissue

A clinical trial of Breast Cancer, sponsored by M.D. Anderson Cancer Center.

Recruiting
Registry status
1,000
Enrollment target
1
Study location

NCT06127797: Recruiting study of Breast Cancer, sponsored by M.D. Anderson Cancer Center.

NCT06127797 is a study of Breast Cancer that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 1,000 participants, below the 2,802-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (64% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06127797, a study of Breast Cancer, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.

RECRUITING
Registry status
1,000 participants
Enrollment target
1
Study location

Study Summary

To create a registry (database) of participants who come in for breast MRI scans. Researchers want to use this information to study if participants with dense breast tissue (tissue that is more difficult to see on mammogram).

Conditions Studied

Interventions

  • BEHAVIORAL Questionnaire/Interview

Study Locations (1)

Texas

  • MD Anderson Cancer Center - Houston

Trial Details

FieldValue
Enrollment Target 1,000 participants
Start Date 2024-01-11
Est. Completion 2029-08-31

Sponsor

M.D. Anderson Cancer Center

2,692 total trials

What the Registry Record Tells You About NCT06127797

The ClinicalTrials.gov registry entry for NCT06127797 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,802-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (64% lower). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which Questionnaire/Interview is the first listed.

NCT06127797 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT06127797 about?

NCT06127797 is a clinical study titled "Surveillance MRI Registry for Patients Who Had Breast Cancer With Dense Breast Tissue". To create a registry (database) of participants who come in for breast MRI scans. Researchers want to use this information to study if participants with dense breast tissue (tissue that is more difficult to see on mammogram).

What is the current status of trial NCT06127797?

This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2024-01-11. Estimated completion is 2029-08-31.

What conditions does trial NCT06127797 study?

This clinical trial studies the following conditions: Breast Cancer.

What interventions are being tested in trial NCT06127797?

The interventions under investigation include: Questionnaire/Interview (BEHAVIORAL).

Who is sponsoring clinical trial NCT06127797?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06127797 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.